000 | 00699nam a22002417a 4500 | ||
---|---|---|---|
003 | OSt | ||
005 | 20250730093944.0 | ||
008 | 250730b |||||||| |||| 00| 0 eng d | ||
020 | _a9781849800143 | ||
040 | _cDLC | ||
041 | _aEnglish | ||
082 |
_220th _a615.11724 _bSHI |
||
100 |
_aShadlen, K. C., et al. _915974 |
||
245 |
_aIntellectual Property, Pharmaceuticals and Public Health: _baccess to drugs in developing countries |
||
260 |
_aUK: _bEdward Elgar, _c2011 |
||
300 | _axi, 338p. | ||
563 | _aHardcover | ||
650 |
_aPublic Health _9412 |
||
650 |
_aPharmaceutical Chemistry _913670 |
||
650 |
_aPharmacology _9299 |
||
650 |
_aMedical Practice _912011 |
||
942 |
_2ddc _cBK |
||
999 |
_c14174 _d14158 |